Study on the Interaction Between C3 Gene Polymorphism and Environment in Patients with Type 2 Diabetes Combined with Coronary Artery Disease
DOI: https://doi.org/10.2147/dmso.s447789
2024-03-27
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Haitang Qiu, 1, &ast Shajidan Abudureyimu, 1, &ast Mengjia Liu, 1 Fen Liu, 2 Ying Gao 1 1 Department of Comprehensive Internal Medicine, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, People's Republic of China; 2 State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Clinical Medical Research, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ying Gao, Department of Comprehensive Internal Medicine, The First Affiliated Hospital of Xinjiang Medical University, 137 Liyushan South Road, Urumqi, Xinjiang, 830054, People's Republic of China, Tel +86-991-4362625, Email Objective: This study was conducted to investigate the combined effect of genetic variation in the C3 gene and environmental factors on the risk of type 2 diabetes mellitus(T2DM) and coronary artery disease(CAD) in a population from Xinjiang, China. Methods: We conducted a hospital-based case-control study with 896 participants (217 with T2DM+CAD and 679 healthy controls). A polymerase chain reaction-ligase detection reaction was used to identify and genotype TagSNPs in the C3 gene, and the influence of the interaction of two SNP loci (rs1047286 and rs11569562) with the environment on T2DM combined with CAD was evaluated through clinical data, statistical analysis of gene frequencies, and the formation of a gene-environment interaction model. Results: We find that rs11569562 GG is an independent protective factor for T2DM and CAD (OR=0.353, p=0.012), and the variants at its locus may be closely associated with Activated Partial Thromboplastin Time (APTT), lipoprotein a (Lp(a)), Apolipoprotein A (APOA), Aspartate Aminotransferase (AST), Aspartate Aminotransferase (ALT) and AST/ALT levels (all P < 0.05); its GG genotype has significantly lower Gensini score and number of stenoses than the GA and AA genotypes. Multifactorial dimensionality reduction (MDR) finds a strong correlation between rs11569562 and AST (antagonistic effect) (4.44%); the role of rs11569562's influence remains strong in terms of the independent effects of each attribute (1.72%). Conclusions: In this study, we find that variants in the C3 gene loci rs11569562 are associated with the incidence of type 2 diabetes mellitus combined with coronary heart disease in a Chinese population. It is expected to be an independent predictor of type 2 diabetes mellitus combined with coronary heart disease in the Chinese population. Rs11569562 may be associated with lipid levels and coagulation molecules. Clinical Trial Registration: This trial registered on in 2014 at the China Clinical Trials Registry (ChiCTR-TRC-14005114). Keywords: coronary heart disease, Type 2 diabetes mellitus, complement C3 Type 2 diabetes mellitus (T2DM) is a chronic, progressive disease that is characterized by years of insulin resistance and hyperinsulinemia preceding the onset of hyperglycemia. 1–3 Nearly 9% of adults globally have diabetes, and the number of people with it is rising in many areas. 4 More than 415 million persons globally, including 109.6 million persons in China, have been found to have diabetes. 5 On a global scale, more than 20% of those aged over 65 have diabetes, and more than 90% of those patients have type 2 diabetes. 6 It is commonly accepted that factors related to lifestyle, the environment, and genetics can affect the development of T2DM. 7,8 T2DM's etiology and progression are regulated by complex interactions between numerous genes and several environmental factors. 9,10 T2DM is linked to an increased risk of coronary heart disease 11 and is the sixth most common cause of disability. 12 Having diabetes plus having established atherosclerotic cardiovascular disease (ASCVD) puts people at a significant risk for recurring major adverse cardiovascular events (MACE). 13 In fact, cardiovascular disease is the main cause of mortality among diabetic patients. T2DM's long-term impacts include the potential to increase morbidity and mortality cardiovascular disease (CVD) is the main cause of death in persons with type 2 diabetes (T2DM), and T2DM is a well-known risk factor for CVD. 14 In comparison to those without diabetes, patients with T2DM have a 2- to 4-fold increased risk of dying from cardiovascular disease (CVD). 15 Therefore, early prediction, identification of at-risk patients, and improved therapeutic management depend on a better understanding of the etiology of CVD and -Abstract Truncated-
endocrinology & metabolism